Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Ophthalmology. 2020 Aug 25;128(3):425–442. doi: 10.1016/j.ophtha.2020.08.018

Table 2.

Results of the proportional hazards regression modeling of progression to late age-related macular degeneration outcomes, according to quintiles of nutrient intake in the combined AREDS/AREDS2 cohort: hazard ratios and P values.

Nutrient Late AMD Geographic Atrophy Neovascular AMD
Q4 vs Q1 Q5 vs Q1 Q4 vs Q1 Q5 vs Q1 Q4 vs Q1 Q5 vs Q1
Vitamin A (IU) 0.80 (0.72, 0.89) 0.82 (0.74, 0.91) 0.76 (0.65, 0.87) 0.77 (0.66, 0.89) 0.85 (0.73, 0.98) 0.83 (0.72, 0.96)
<.0001 0.0001 0.0002 0.0005 0.022 0.013
Retinol 0.97 (0.86, 1.08) 0.96 (0.86, 1.08) 0.97 (0.83, 1.14) 0.98 (0.84, 1.16) 0.98 (0.84, 1.14) 0.97 (0.83, 1.13)
0.53 0.54 0.70 0.85 0.82 0.68
Vitamin D 0.94 (0.84, 1.05) 0.95 (0.86, 1.06) 0.91 (0.78, 1.06) 0.86 (0.74, 1.00) 1.07 (0.92, 1.25) 1.13 (0.97, 1.31)
0.25 0.40 0.21 0.053 0.36 0.12
Vitamin E 0.97 (0.87, 1.10) 0.94 (0.83, 1.06) 1.02 (0.85, 1.21) 0.96 (0.80, 1.14) 1.03 (0.88, 1.21) 0.96 (0.81, 1.14)
0.67 0.33 0.86 0.64 0.72 0.63
Vitamin C 0.79 (0.71, 0.87) 0.80 (0.72, 0.89) 0.71 (0.62, 0.83) 0.70 (0.60, 0.81) 0.87 (0.75, 1.00) 0.92 (0.79, 1.06)
<.0001 <.0001 <.0001 <.0001 0.056 0.25
Thiamine 0.88 (0.79, 0.97) 0.90 (0.81, 1.00) 0.87 (0.75, 1.01) 0.85 (0.73, 0.99) 1.00 (0.86, 1.16) 0.99 (0.85, 1.16)
0.015 0.057 0.068 0.033 0.99 0.91
Riboflavin 0.91 (0.82, 1.01) 0.91 (0.81, 1.01) 0.81 (0.70, 0.94) 0.81 (0.70, 0.95) 1.07 (0.92, 1.25) 1.04 (0.89, 1.21)
0.088 0.078 0.005 0.008 0.36 0.64
Niacin 0.87 (0.78, 0.97) 0.85 (0.76, 0.95) 0.86 (0.74, 1.00) 0.79 (0.68, 0.93) 0.89 (0.77, 1.04) 0.92 (0.79, 1.07)
0.012 0.005 0.044 0.004 0.14 0.27
Vitamin B6 0.82 (0.73, 0.92) 0.83 (0.74, 0.93) 0.79 (0.68, 0.92) 0.85 (0.73, 0.99) 0.85 (0.73, 0.98) 0.82 (0.70, 0.95)
0.0004 0.001 0.003 0.035 0.030 0.010
Folate 0.82 (0.74, 0.92) 0.82 (0.73, 0.91) 0.71 (0.61, 0.82) 0.78 (0.67, 0.91) 0.92 (0.80, 1.07) 0.87 (0.75, 1.02)
0.0004 0.0002 <.0001 0.002 0.29 0.077
Vitamin B12 0.93 (0.83, 1.04) 0.96 (0.85, 1.07) 0.82 (0.70, 0.96) 0.91 (0.78, 1.07) 0.98 (0.84, 1.14) 0.99 (0.85, 1.15)
0.19 0.43 0.011 0.24 0.77 0.92
Beta-carotene 0.78 (0.70, 0.87) 0.81 (0.73, 0.90) 0.74 (0.63, 0.85) 0.75 (0.64, 0.87) 0.83 (0.72, 0.97) 0.88 (0.76, 1.02)
<.0001 0.0001 <.0001 0.0001 0.016 0.088
Alpha-carotene 0.92 (0.83, 1.03) 0.95 (0.85, 1.05) 0.90 (0.77, 1.05) 0.96 (0.83, 1.11) 1.01 (0.87, 1.17) 0.93 (0.81, 1.08)
0.14 0.31 0.18 0.59 0.92 0.36
Beta-cryptoxanthin 0.87 (0.78, 0.97) 0.91 (0.82, 1.01) 0.82 (0.70, 0.95) 0.80 (0.68, 0.93) 0.94 (0.81, 1.09) 0.98 (0.84, 1.14)
0.011 0.080 0.009 0.004 0.39 0.77
Lutein and zeaxanthin 0.74 (0.67, 0.83) 0.77 (0.69, 0.85) 0.77 (0.66, 0.90) 0.80 (0.68, 0.93) 0.78 (0.68, 0.91) 0.83 (0.71, 0.96)
<.0001 <.0001 0.0007 0.004 0.0015 0.013
Lycopene 0.96 (0.86, 1.07) 0.90 (0.81, 1.01) 0.82 (0.71, 0.95) 0.81 (0.70, 0.94) 1.03 (0.89, 1.19) 0.97 (0.84, 1.13)
0.50 0.064 0.010 0.005 0.68 0.73
Calcium 0.99 (0.89, 1.10) 0.87 (0.78, 0.98) 0.90 (0.77, 1.04) 0.78 (0.67, 0.91) 1.10 (0.95, 1.27) 0.96 (0.82, 1.13)
0.83 0.020 0.15 0.002 0.22 0.65
Magnesium 0.86 (0.77, 0.95) 0.79 (0.71, 0.88) 0.83 (0.71, 0.96) 0.73 (0.62, 0.85) 0.88 (0.76, 1.02) 0.81 (0.70, 0.95)
0.005 <.0001 0.013 <.0001 0.084 0.007
Iron 0.85 (0.77, 0.95) 0.91 (0.81, 1.01) 0.80 (0.69, 0.93) 0.82 (0.71, 0.96) 0.97 (0.83, 1.12) 1.01 (0.87, 1.17)
0.004 0.081 0.004 0.011 0.66 0.92
Zinc 0.95 (0.85, 1.05) 0.96 (0.86, 1.07) 0.86 (0.74, 0.99) 0.90 (0.77, 1.05) 1.05 (0.91, 1.22) 1.01 (0.87, 1.17)
0.31 0.45 0.042 0.17 0.47 0.93
Copper 0.83 (0.74, 0.93) 0.79 (0.70, 0.89) 0.77 (0.66, 0.90) 0.71 (0.60, 0.83) 0.84 (0.72, 0.98) 0.86 (0.73, 1.01)
0.0015 0.0001 0.0009 <.0001 0.027 0.061
Cholesterol 1.12 (1.00, 1.26) 1.12 (1.00, 1.26) 1.14 (0.98, 1.34) 1.17 (1.00, 1.37) 1.05 (0.90, 1.23) 1.11 (0.95, 1.29)
0.046 0.053 0.10 0.051 0.51 0.21
Saturated fat 1.12 (1.01, 1.24) 1.32 (1.19, 1.48) 1.17 (1.00, 1.36) 1.39 (1.20, 1.63) 1.06 (0.91, 1.23) 1.26 (1.09, 1.46)
0.038 <.0001 0.049 <.0001 0.44 0.002
Monounsaturated fat 1.15 (1.03, 1.29) 1.23 (1.10, 1.38) 1.23 (1.05, 1.43) 1.30 (1.11, 1.52) 1.16 (0.99, 1.35) 1.25 (1.07, 1.46)
0.012 0.0002 0.009 0.0009 0.061 0.005
Oleic acid 1.13 (1.01, 1.26) 1.28 (1.14, 1.43) 1.17 (1.00, 1.37) 1.42 (1.22, 1.66) 1.15 (0.98, 1.34) 1.28 (1.10, 1.50)
0.029 <.0001 0.057 <.0001 0.086 0.002
Linoleic acid 1.03 (0.92, 1.15) 1.16 (1.03, 1.30) 1.11 (0.95, 1.30) 1.30 (1.10, 1.52) 0.97 (0.83, 1.12) 1.07 (0.92, 1.25)
0.58 0.014 0.19 0.002 0.65 0.39
Alpha-linolenic acid 1.07 (0.96, 1.19) 1.07 (0.96, 1.20) 1.06 (0.91, 1.23) 1.14 (0.98, 1.32) 1.09 (0.94, 1.26) 1.02 (0.88, 1.18)
0.20 0.20 0.45 0.089 0.26 0.80
Arachidonic acid 1.01 (0.90, 1.14) 1.05 (0.93, 1.18) 1.01 (0.86, 1.19) 1.02 (0.86, 1.20) 0.95 (0.81, 1.12) 1.06 (0.90, 1.25)
0.89 0.46 0.90 0.84 0.56 0.46
EPA 0.85 (0.76, 0.96) 0.83 (0.74, 0.93) 0.80 (0.69, 0.93) 0.76 (0.65, 0.89) 0.91 (0.78, 1.06) 0.92 (0.79, 1.07)
0.006 0.0009 0.004 0.0008 0.23 0.30
DHA 0.84 (0.75, 0.95) 0.83 (0.73, 0.93) 0.78 (0.67, 0.92) 0.74 (0.63, 0.88) 0.85 (0.73, 1.00) 0.93 (0.79, 1.09)
0.004 0.002 0.002 0.0006 0.044 0.38
EPA and DHA 0.86 (0.76, 0.96) 0.85 (0.76, 0.96) 0.81 (0.70, 0.95) 0.79 (0.67, 0.93) 0.85 (0.72, 0.99) 0.95 (0.81, 1.11)
0.008 0.009 0.010 0.005 0.038 0.51
Lactose 1.02 (0.91, 1.14) 0.97 (0.87, 1.09) 0.98 (0.84, 1.15) 0.93 (0.79, 1.09) 1.11 (0.96, 1.29) 1.01 (0.86, 1.18)
0.73 0.61 0.85 0.39 0.16 0.93
Alcohol 0.79 (0.72, 0.88) 0.85 (0.77, 0.93) 0.74 (0.65, 0.85) 0.86 (0.75, 0.98) 0.84 (0.73, 0.96) 0.83 (0.73, 0.95)
<.0001 0.0008 <.0001 0.023 0.009 0.006

Abbreviations: AMD=age-related macular degeneration; DHA=docosahexaenoic acid; EPA=eicosapentaenoic acid; IU=international units; Q=quintile

Footnotes:

- results are shown in comparison to quintile 1 (reference), following adjustment for age, sex, smoking status, total calorie intake, body mass index (for AREDS participants only), and correlation between eyes

- AREDS2 data: the results for late AMD are based on events over the full study period (i.e., including the AREDS2 10-year follow-on study), while the results for geographic atrophy and neovascular AMD are based on events up until the AREDS2 close-out (median 5 years). This is because, in the AREDS2 10-year follow-on study, late AMD subtype information was not captured from all data sources